Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Comparison of the Hepatitis C Continua of Care Between Hepatitis C Virus/HIV Coinfected and Hepatitis C Virus Mono-Infected Patients in Two Treatment Eras During 2008-2015.

Roberson JL, Lagasca AM, Kan VL.

AIDS Res Hum Retroviruses. 2018 Feb;34(2):148-155. doi: 10.1089/AID.2017.0092. Epub 2017 Nov 8.

PMID:
28974107
2.

Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption.

Lee WS, Kristensen AB, Rasmussen TA, Tolstrup M, Østergaard L, Søgaard OS, Wines BD, Hogarth PM, Reynaldi A, Davenport MP, Emery S, Amin J, Cooper DA, Kan VL, Fox J, Gruell H, Parsons MS, Kent SJ.

J Virol. 2017 Jul 12;91(15). pii: e00603-17. doi: 10.1128/JVI.00603-17. Print 2017 Aug 1.

3.

Hepatitis C Virus Continuum of Care in the Interferon and Direct-Acting Agent Eras Among HIV-Coinfected Patients.

Roberson JL, Kan VL.

AIDS Res Hum Retroviruses. 2017 May;33(5):405-406. doi: 10.1089/AID.2016.0170. Epub 2017 Feb 16. No abstract available.

PMID:
28094566
4.

Making Longitudinal Progress in the HIV Care Continuum Within an Urban Veterans Affairs Clinic.

Lagasca AM, Kan VL.

AIDS Patient Care STDS. 2015 Nov;29(11):579-81. doi: 10.1089/apc.2015.0141. Epub 2015 Sep 8. No abstract available.

5.

Hepatitis C Treatment at a Veterans Affairs Medical Center After the Availability of Direct-Acting Agents: Things Are Looking Up.

Lagasca AM, Kan VL.

Clin Infect Dis. 2015 Oct 15;61(8):1347-9. doi: 10.1093/cid/civ573. Epub 2015 Jul 17. No abstract available.

PMID:
26187023
6.

Rates and Predictors of Newly Diagnosed HIV Infection Among Veterans Receiving Routine Once-Per-Lifetime HIV Testing in the Veterans Health Administration.

Goetz MB, Hoang T, Kan VL, Rimland D, Rodriguez-Barradas MC, Asch SM.

J Acquir Immune Defic Syndr. 2015 Aug 15;69(5):544-50. doi: 10.1097/QAI.0000000000000653.

7.

True durability: HIV virologic suppression in an urban clinic and implications for timing of intensive adherence efforts and viral load monitoring.

Benator DA, Elmi A, Rodriguez MD, Gale HB, Kan VL, Hoffman HJ, Tramazzo S, Hall K, McKnight A, Squires L.

AIDS Behav. 2015 Apr;19(4):594-600. doi: 10.1007/s10461-014-0917-6.

8.

Risk assessment for healthcare workers after a sentinel case of rabies and review of the literature.

Kan VL, Joyce P, Benator D, Agnes K, Gill J, Irmler M, Clark A, Giannakos G, Gabourel A, Gordin FM.

Clin Infect Dis. 2015 Feb 1;60(3):341-8. doi: 10.1093/cid/ciu850. Epub 2014 Oct 28. Review.

PMID:
25352591
9.

Development and validation of an algorithm to identify patients newly diagnosed with HIV infection from electronic health records.

Goetz MB, Hoang T, Kan VL, Rimland D, Rodriguez-Barradas M.

AIDS Res Hum Retroviruses. 2014 Jul;30(7):626-33. doi: 10.1089/AID.2013.0287. Epub 2014 Mar 20.

10.

Progress realized: trends in HIV-1 viral load and CD4 cell count in a tertiary-care center from 1999 through 2011.

Gale HB, Rodriguez MD, Hoffman HJ, Benator DA, Gordin FM, Labriola AM, Kan VL.

PLoS One. 2013;8(2):e56845. doi: 10.1371/journal.pone.0056845. Epub 2013 Feb 20.

11.

Is frequent CD4+ T-lymphocyte count monitoring necessary for persons with counts >=300 cells/μL and HIV-1 suppression?

Gale HB, Gitterman SR, Hoffman HJ, Gordin FM, Benator DA, Labriola AM, Kan VL.

Clin Infect Dis. 2013 May;56(9):1340-3. doi: 10.1093/cid/cit004. Epub 2013 Jan 11.

12.

Performance of the Abbott RealTime HCV Genotype II RUO assay.

Shinol RC, Gale HB, Kan VL.

J Clin Microbiol. 2012 Sep;50(9):3099-101. doi: 10.1128/JCM.01249-12. Epub 2012 Jul 3.

13.

Candidemia outcomes not improved with statin use.

Welch ML, Liappis AP, Kan VL.

Med Mycol. 2013 Feb;51(2):219-22. doi: 10.3109/13693786.2012.692490. Epub 2012 Jun 4.

PMID:
22662759
14.

Greater HIV testing after Veterans Health Administration policy change: the experience from a VA Medical Center in a high HIV prevalence area.

Nayak SU, Welch ML, Kan VL.

J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):165-8. doi: 10.1097/QAI.0b013e318251aefe.

PMID:
22627183
15.

Baseline E138 reverse transcriptase resistance-associated mutations in antiretroviral-naive HIV-infected patients.

Siegel MO, Swierzbinski M, Kan VL, Parenti DM.

AIDS. 2012 Jun 1;26(9):1181-2. doi: 10.1097/QAD.0b013e32835393e9. No abstract available.

PMID:
22592071
16.

Comparison of serial Hepatitis C virus detection in samples submitted through serology for reflex confirmation versus samples directly submitted for quantitation.

Gale HB, Dufour DR, Qazi NN, Kan VL.

J Clin Microbiol. 2011 Aug;49(8):3036-9. doi: 10.1128/JCM.00577-11. Epub 2011 Jun 8.

17.

Rapid oral HIV screening: expectations revisited.

Rexroth K, Hare K, Kan VL.

J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):e59-60. doi: 10.1097/QAI.0b013e3181fe7eb2. No abstract available.

PMID:
21233634
18.

Assessing targeted screening and low rates of HIV testing.

Kennedy LA, Gordin FM, Kan VL.

Am J Public Health. 2010 Sep;100(9):1765-8. doi: 10.2105/AJPH.2009.182790. Epub 2010 Jul 15.

19.

HIV testing at a VA Medical Center in a high prevalence area after VHA policy change: things are looking up.

Kan VL.

J Acquir Immune Defic Syndr. 2010 Jul;54(3):e1-2. doi: 10.1097/QAI.0b013e3181e15c0c. No abstract available.

PMID:
20571413
20.

Raltegravir for postexposure prophylaxis following occupational exposure to HIV.

Siegel MO, Kan VL, Benator DA.

AIDS. 2008 Nov 30;22(18):2552-3. doi: 10.1097/QAD.0b013e328318f184. No abstract available.

PMID:
19005284
21.

Trichosporon asahii infection in an advanced AIDS patient and literature review.

Gross JW, Kan VL.

AIDS. 2008 Mar 30;22(6):793-5. doi: 10.1097/QAD.0b013e3282f51ecc. Review. No abstract available.

PMID:
18356615
22.

Mannitol and inflammatory markers in the cerebral spinal fluid of HIV-infected patients with cryptococcal meningitis.

Liappis AP, Kan VL, Richman NC, Yoon B, Wong B, Simon GL.

Eur J Clin Microbiol Infect Dis. 2008 Jun;27(6):477-9. doi: 10.1007/s10096-008-0462-1. Epub 2008 Feb 12. No abstract available.

PMID:
18266014
23.

Macrolide and clindamycin resistance in Staphylococcus aureus isolates and antibiotic use in a Veterans Affairs Medical Center.

Modak R, Ross D, Kan VL.

Infect Control Hosp Epidemiol. 2008 Feb;29(2):180-2. doi: 10.1086/526448.

PMID:
18179375
24.
25.

Durable neutralizing antibodies after remote smallpox vaccination among adults with and without HIV infection.

Kan VL, Manischewitz J, King LR, Golding H.

AIDS. 2007 Feb 19;21(4):521-4.

PMID:
17301573
26.
27.

Hypokalemia in HIV patients on tenofovir.

Cirino CM, Kan VL.

AIDS. 2006 Aug 1;20(12):1671-3.

PMID:
16868451
28.

Invasive nontypeable Haemophilus influenzae infection in an adult with laryngeal cancer.

Turner TD, Zelazny AM, Kan VL.

Diagn Microbiol Infect Dis. 2006 May;55(1):85-7. Epub 2006 Feb 20.

PMID:
16490337
30.

Erysipelothrix rhusiopathiae septic arthritis.

Ruiz ME, Richards JS, Kerr GS, Kan VL.

Arthritis Rheum. 2003 Apr;48(4):1156-7.

31.

Nonoperative management of diabetic foot infections.

Wakefield MC, Kan VL, Arora S, Weiswasser J, Sidawy AN.

Semin Vasc Surg. 2003 Mar;16(1):79-85. Review. No abstract available.

PMID:
12644977
32.

The effect of statins on mortality in patients with bacteremia.

Liappis AP, Kan VL, Rochester CG, Simon GL.

Clin Infect Dis. 2001 Oct 15;33(8):1352-7. Epub 2001 Sep 20.

PMID:
11565076
33.

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.

Stevens DA, Kan VL, Judson MA, Morrison VA, Dummer S, Denning DW, Bennett JE, Walsh TJ, Patterson TF, Pankey GA.

Clin Infect Dis. 2000 Apr;30(4):696-709. Epub 2000 Apr 20.

PMID:
10770732
34.

Salmonella typhimurium brain abscess: postoperative complication.

Kumari P, Kan VL.

Clin Infect Dis. 2000 Mar;30(3):621-2. Review. No abstract available.

PMID:
10722467
35.

Diabetic ketoacidosis in an HIV patient: a new mechanism of HIV protease inhibitor-induced glucose intolerance.

Kan VL, Nylen ES.

AIDS. 1999 Oct 1;13(14):1987-9. No abstract available.

PMID:
10513665
36.

Enhanced oxidative killing of azole-resistant Candida glabrata strains with ERG11 deletion.

Kan VL, Geber A, Bennett JE.

Antimicrob Agents Chemother. 1996 Jul;40(7):1717-9.

37.

Decline in the incidence of cryptococcosis among HIV-infected patients.

McNeil JI, Kan VL.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jun 1;9(2):206-8. No abstract available.

PMID:
7749801
38.

Polymerase chain reaction for the diagnosis of candidemia.

Kan VL.

J Infect Dis. 1993 Sep;168(3):779-83.

PMID:
8354923
39.

Comparative safety, tolerance, and pharmacokinetics of amphotericin B lipid complex and amphotericin B desoxycholate in healthy male volunteers.

Kan VL, Bennett JE, Amantea MA, Smolskis MC, McManus E, Grasela DM, Sherman JW.

J Infect Dis. 1991 Aug;164(2):418-21.

PMID:
1856491
40.
41.

Efficacies of four antifungal agents in experimental murine sporotrichosis.

Kan VL, Bennett JE.

Antimicrob Agents Chemother. 1988 Nov;32(11):1619-23.

42.
43.

Bioassay for SF 86-327, a new antifungal agent.

Kan VL, Henderson DK, Bennett JE.

Antimicrob Agents Chemother. 1986 Oct;30(4):628-9.

44.

Supplemental Content

Support Center